VRTX is the stock ticker for Vertex Pharmaceuticals, Inc which was among the very first in Biotech to “use an explicit strategy of rational drug design rather than combinatorial chemistry”.

It is publicly traded on NASDAQ stock exchange.

Vertex Pharmaceuticals, Inc (VRTX) innovation in Biotech has paid off for them with VRTX stock prices soaring up to almost $200 a share in 2018.